Tumor-specific targeting of T helper type 1 (Th1) cells by anti-CD3 x anti-c-ErbB-2 bispecific antibody

Cancer Immunology Immunotherapy

Volumn 48, Issue 8, 1999, Pages 456-462

  Ohmi, Yasushi ^b   Shiku, Hiroshi ^c   Nishimura, Takashi ^a,d  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAGAWA DENTAL COLLEGE   (Japan)

^c MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Bispecific antibody; C erbB 2; Interleukin 12; Th1; Th2; Tumor immunotherapy

Indexed keywords

ANTIBODY; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY CD3; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CYTOTOXICITY; HELPER CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; PRIORITY JOURNAL; TUMOR CELL CULTURE; TUMOR LOCALIZATION;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RECEPTOR, ERBB-2; RECEPTORS, ANTIGEN, T-CELL; TH1 CELLS; TH2 CELLS; TUMOR CELLS, CULTURED;

EID: 0032744662     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050622     Document Type: Article

References (30)

1. Fanger MW, Segal DM, Romet-Lemone JL (1991) Bispecific antibodies and targeted cellular cytotoxicity. Immunol Today 12:51
2. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM (1989) Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 169:59
3. Hsieh CS, Heimberger AB, Gold JS, O'garra A, Murphy KM (1992) Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proc Natl Acad Sci USA 89:6065
4. Hoffman RW, Bluestone JA, Leo O, Shaw S (1985) Lysis of anti-T3-bearing-murine hybridoma cells by human allospecific cytotoxicic T cell clone and inhibition of that lysis by anti-T3 and anti-LFA-1 antibodies. J Immunol 135:5
5. Krosen BJ, Wellenberg GJ, Bakker A, Helfrich W, The Th, Leij L, (1996) The role of apotosis in the bispecific antibody-mediated T-cell cytotoxicity. Br J Cancer 73:721
6. + cytotoxicic T lymphocytes from tumor-infiltrating lymphocytes. Jpn J Cancer Res 86:135
7. Masuko T, Sugahara K, Kondou M, Otsuki S, Akiyama T, Yamamoto T, Toyoshida K, Hashimoto Y (1989) A murine monoclonal antibody that recognizes an extracellular domain of the human c-erbB-2 protooncogene product. Jpn J Cancer Res 80:10
8. Mosmann TR, Coffman RL (1989) Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145
9. Mule JJ, Shu S, Schwarz SL, Rosenberg SA (1984) Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science 225:1487
10. +TCR-lo thymocytes in vivo. Science 250:1720
11. Nagata Y, Furugen R, Hiasa A, Ikeda H, Ohta N, Furukawa K, Nakamura H, Furukawa K, Kanemasu T, Shiku H (1997) Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngenic hosts. J Immunol 159:1336
12. Nishimura T, Togashi Y, Goto M, Yagi H, Uchiyama Y, Hashimoto Y (1986) Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2. Cancer Immunol Immunother 21:8
13. Nishimura T, Burakoff SJ, Hermann SH (1987) Protein kinase C required for cytotoxicic T lymphocyte triggering. J Immunol 130:2888
14. + thymocytes in vitro. J Immunol 145:4012
15. + helper/killer T cells induced by anti CD3 monoclonal antibody plus interleukin 2. Jpn J Cancer Res 82:1207
16. Nishimura T, Nakamura Y, Tukamoto H, Takeuchi Y, Tokuda Y, Iwasawa M, Yamamoto T, Masuko, Hashimoto Y, Habu S (1992) Human c-erbB-2 proto-oncogene product as a target for bispecific-antibody-directed adoptive tumor immunotherapy. Int J Cancer 50:800
17. + helper/killer T cells induced by anti CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy. J Immunol 148:285
18. Nishimura T, Watanabe K, Yahata T, Lee U, Ando K, Kimura M, Saiki I, Ueda T, Habu S (1996) Application of interleukin 12 to antitumor cytokine and gene therapy. Can Chemother Pharmacol 38:27
19. 2 monomer prepared with anti CD3 and anti-tumor monoclonal antibodies is most potent in induction of cytolysis of human T cells. Eur J Immunol 19:1437
20. Perez PR, Hoffman W, Shaw S, Bluestone JA, Segal DM (1985) Specific targeting of cytotoxicic T cells by anti-T3 linked to anti-target cells antibody. Nature 316:354
21. Robert B, Mach J, Mani J, Ychou M, Folli S, Artus J, Pelegrin A (1996) Cytokine targeting in using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor α. Cancer Res 56:4758
22. Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AV, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson C, Reichert CM (1985) Observation on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 315:1485
23. Scott P, Kaufmann SHE (1991) The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 12:346
24. Sypek JP, Chung CL, Mayor SEH, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 177:1797
25. Titus JA, Garrido MA, Hecht TT, Winkler DF, Wunderlich JR, Segal DM (1987) Human T cell targeted with anti-T3 cross-linked to antitumor antibody prevent tumor growth in nude mice. J Immunol 139:2545
26. Tomonari K (1988) A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex. Immunogenetics 28:455
27. Torinchieri G (1994) Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cell type 1 and cytotoxicic lymphocytes. Blood 84:4008
28. Tukamoto H, Nakamura Y, Masuko T, Hashimoto Y, Habu S, Nishimura T (1993) Specific targeting of in vitro-activated human antitumor effector cells using anti-CD3 × anti-c-ErbB-2 bispecific antibody. Immunol Cell Biol 71:109
29. Van Seventer GA, Kuijpers KC, Van Lier RAW, De Groot ERD, Aarden LA, Melief CJM (1987) Mechanism of inhibition and induction of cytotoxicity activity in cytotoxicic T lymphocytes by CD3 monoclonal antibodies. J Immunol 139:2545
30. Vercelli D, Jabara HH, Lauener RP, Geha RS (1990) IL-4 inhibits the synthesis of IFN-γ and induces the synthesis of IgE in human mixed lymphocyte cultures. J Immunol 144:570